Investigations

1st investigations to order

unconjugated bilirubin

Test
Result
Test

Repeated measurements to document elevated levels 6 to 18 months after initial elevated level.

Result

elevated; usually <68.4 micromol/L (<4 mg/dL) and invariably <102 micromol/L (<6 mg/dL)

liver aminotransferases

Test
Result
Test

Repeated measurements after 6-18 months to ensure that levels remain normal. If repeat levels are elevated, workup for alternative causes is required.

Result

normal

gamma-glutamyl transpeptidase

Test
Result
Test

Repeated measurements after 6-18 months to ensure that levels remain normal. If repeat levels are elevated, workup for alternative causes is required.

Result

normal

lactate dehydrogenase

Test
Result
Test

Repeated measurements after 6-18 months to ensure that levels remain normal. If repeat levels are elevated, workup for alternative causes is required.

Result

normal

FBC

Test
Result
Test

Repeated measurements after 6-18 months to ensure that levels remain normal. If repeat levels are elevated, workup for alternative causes is required.

Result

normal

peripheral blood smear

Test
Result
Test

Repeated measurements after 6-18 months to ensure that results remain normal. If repeat results are abnormal, workup for alternative causes is required.

Result

normal

direct Coombs' test

Test
Result
Test

To exclude ABO or Rh isoimmunisation as a cause of haemolytic anaemia.

Result

negative

Investigations to consider

liver biopsy

Test
Result
Test

Liver biopsy is not usually necessary. Performance of a liver biopsy is recommended only if persistent elevation of unconjugated bilirubin is otherwise unexplained, is symptomatic, is worsening over time, and/or associated with abnormal transaminases.[19]

Result

usually normal; may have an accumulation of a lipofuscin-like pigment around the terminal hepatic venules; may demonstrate features of co-existing liver disease if present

plasma unconjugated bilirubin response to fasting

Test
Result
Test

GS patients who consume a diet of ≤400 kcal/day will have a 2- to 3-fold rise in the plasma unconjugated bilirubin level within 48 hours of initiating the fast. The level should return to normal with the resumption of a normal diet. The same effect may be seen with a normal diet that is devoid of lipids. The bilirubin level again should normalise when lipids are restored in the diet. The mechanism of these processes is not entirely understood.[22]

Result

2- to 3-fold rise in plasma unconjugated bilirubin level on fasting if patient consumes a diet of ≤400 kcal/day, or a diet devoid of lipids, observed within 48 hours of initiating the fast; level should return to normal within 2 to 3 days upon resumption of a normal diet

plasma unconjugated bilirubin response to nicotinic acid

Test
Result
Test

Normal subjects, or those with haemolysis, have more modest or no increase in bilirubin level.[8] This test is rarely needed but may be of value in cases of diagnostic uncertainty, and in the further characterisation of confirmed cases.

Result

2- to 3-fold rise in the plasma unconjugated bilirubin level within 3 hours after intravenous administration of nicotinic acid 50 mg

UGT1A1 genotyping

Test
Result
Test

Polymerase chain reaction can be used to identify mutations and genetic polymorphisms (e.g., UGT1A1*28) found in the TATA promoter region of the UGT1A1 gene.[20][21]

While not routinely used in the diagnostic work-up of GS, this may be of value in cases of diagnostic uncertainty, and in the further characterisation of confirmed cases.

Result

presence of mutation ± prognostic polymorphisms (e.g., UGT1A1*28)

UDPGT enzyme activity

Test
Result
Test

Although serum bilirubin concentrations act as an indirect measure of uridine-diphosphoglucuronate glucuronosyltransferase (UDPGT) activity, direct assays of UDPGT enzymatic activity can be performed.[21]

While not routinely used in the diagnostic work-up of GS, this may be of value in cases of diagnostic uncertainty, and in the further characterisation of confirmed cases.

Result

reduced activity

Use of this content is subject to our disclaimer